Heartflow, Inc. Common Stock
HTFL
株式のランク
#3566
HeartFlow, Inc. operates as a global medical technology firm, specializing in... HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
株価
$55.33
最終同期: 2026-10-20
時価総額
$4.81B
変化（1日）
8.44%
変化（1年）
51.00%
国
US
取引 Heartflow, Inc. Common Stock (HTFL)
カテゴリー
Healthcare
Heartflow, Inc. Common Stock（HTFL）の配当利回りの履歴
Heartflow, Inc. Common Stock（銘柄コード: HTFL）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
過去5年間の平均配当利回り: 0.00%
Heartflow, Inc. Common Stock（HTFL）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.20% |
US
|
|
| 0.42% |
AU
|
|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
US
|
